Gene · 11065
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic Differences in Medullary Thyroid Carcinoma According to Grade. | Endocr Pathol | 2024 | 38958823 | PubTator, text mining | PubMed |
| UBE2C-induced crosstalk between mono- and polyubiquitination of SNAT2 promotes lymphatic metastasis in bladder cancer. | J Clin Invest | 2024 | 38949026 | PubTator, text mining | PubMed |
| UBE2C orchestrates bone formation through stabilization of SMAD1/5. | Bone | 2024 | 38917963 | PubTator, text mining | PubMed |
| Single-cell analysis uncovers high-proliferative tumour cell subtypes and their interactions in the microenvironment of gastric cancer. | J Cell Mol Med | 2024 | 38894657 | PubTator, text mining | PubMed |
| Deciphering the miRNA-mRNA Interaction Landscape between Breast Cancer and Triple-Negative Breast Cancer: An Integrated Bioinformatics Approach. | ACS Omega | 2024 | 38882157 | PubTator, text mining | PubMed |
| Genetic association mapping leveraging Gaussian processes. | J Hum Genet | 2024 | 38834722 | PubTator, text mining | PubMed |
| UBE2C as an Immune-Related Biomarker for Breast Cancer: A Study Based on Multiple Databases. | Chin Med Sci J | 2024 | 38828693 | PubTator, text mining | PubMed |
| Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment. | Cancer Rep (Hoboken) | 2024 | 38717954 | PubTator, text mining | PubMed |
| Immunotherapy and drug sensitivity predictive roles of a novel prognostic model in hepatocellular carcinoma. | Sci Rep | 2024 | 38664521 | PubTator, text mining | PubMed |
| Disrupting the interaction between a p53 gain-of-function mutant and the transcriptional co-activator PC4 reverses drug resistance in cancer cells. | FEBS Lett | 2024 | 38664232 | PubTator, text mining | PubMed |
| Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis. | Front Cell Dev Biol | 2024 | 38645409 | PubTator, text mining | PubMed |
| Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer. | Aging (Albany NY) | 2024 | 38643462 | PubTator, text mining | PubMed |
| UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation. | BMC Cancer | 2024 | 38637730 | PubTator, text mining | PubMed |
| Mining and exploration of rehabilitation nursing targets for colorectal cancer. | Aging (Albany NY) | 2024 | 38637125 | PubTator, text mining | PubMed |
| UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 38634120 | PubTator, text mining | PubMed |
| Characterization of a G2M checkpoint-related gene model and subtypes associated with immunotherapy response for clear cell renal cell carcinoma. | Heliyon | 2024 | 38617927 | PubTator, text mining | PubMed |
| UBE2C: A pan-cancer diagnostic and prognostic biomarker revealed through bioinformatics analysis. | Cancer Rep (Hoboken) | 2024 | 38577722 | PubTator, text mining | PubMed |
| Exploring effective biomarkers and potential immune related gene in small cell lung cancer. | Sci Rep | 2024 | 38556560 | PubTator, text mining | PubMed |
| DELVE: feature selection for preserving biological trajectories in single-cell data. | Nat Commun | 2024 | 38553455 | PubTator, text mining | PubMed |
| The emerging roles of non-canonical ubiquitination in proteostasis and beyond. | J Cell Biol | 2024 | 38517379 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11065/papers?page=9